Koers genOway SA Xetra
Aandelen
JEH
FR0004053510
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- EUR | - |
|
2023 | GenOway: sterke stijging, broker geeft koopaanbeveling | CF |
2023 | GENOWAY : Euroland opent buy-dekking | CF |
Omzet 2022 | 21,09 mln. 22,55 mln. | Omzet 2023 | 26,51 mln. 28,34 mln. | Marktkapitalisatie | 40,59 mln. 43,4 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | 1 mln. 1,07 mln. | EV/omzet 2022 | 1,87 x |
Nettoschuld 2022 | 4,16 mln. 4,44 mln. | Nettoschuld 2023 | 2,97 mln. 3,18 mln. | EV/omzet 2023 | 1,64 x |
K/w-verhouding 2022 * |
-
| K/w-verhouding 2023 |
-
| Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 72,58% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 01-03-99 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01-10-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-03-99 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,13% | 46,93 mld. | |
+37,29% | 39,08 mld. | |
-8,73% | 38,48 mld. | |
+28,09% | 31,01 mld. | |
-12,26% | 26,14 mld. | |
+10,57% | 25,88 mld. | |
+45,05% | 14,15 mld. | |
+32,23% | 12,53 mld. | |
-6,56% | 11,36 mld. |
- Beurs
- Aandelen
- Koers ALGEN
- Koers JEH